Clinical Trial Update: 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) [Phase 1]

View source ↗

Summary

Phase 1 study update on 131I-TLX-101 for newly diagnosed glioblastoma; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 131I-TLX-101 (Iodine-131 TLX-101)

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Neoplastic Disease, Glioblastoma | Phase 1 | Status: RECRUITING